Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.
about
Affective immunology: where emotions and the immune response converge.Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.Engineering challenges for brain tumor immunotherapy.The Immunology of Behavior-Exploring the Role of the Immune System in Brain Health and Illness.Antidepressant-Like Actions of Inhibitors of Poly(ADP-Ribose) Polymerase in Rodent Models.Imaging the role of inflammation in mood and anxiety-related disorders.Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.Abnormalities in the brain-immune system in psychotic disorders: from pathogenesis to prevention.Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination.Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders.Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E.Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future PerspectiveIncreased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia
P2860
Q33721042-FC4F8369-F8D5-4696-A90C-5A9BE1E00F55Q38726626-3DA659BF-D8A5-44CF-A890-7D693A4A0D9FQ39381281-AAA61D39-999D-4B41-BBEB-ECD0709CC36BQ47123827-31B5F636-0393-4933-AA2D-39B3A4C52BB7Q47148667-37C77585-1DDF-4383-A527-3C43E80F38AEQ47305318-C4D1A8F3-D07A-410D-956E-30744EC18439Q47556460-14C80C31-61BD-4512-A11C-7A423993CB60Q47700280-1BE7221D-847B-4A74-8026-5D95A85713EFQ47744143-6B700C62-568F-46EB-98A7-78EDCF720C2AQ47830428-2E499E63-EBC7-40E2-8C49-B76E5ED5203CQ49957153-3C32CE5B-6492-4D54-A489-C9A98E0DA09EQ55302772-FA5058F6-DA8C-4628-915E-4AFCEC9D2524Q58554142-2331159C-F854-41B4-86ED-711F4E31F442Q58756272-5F508DCC-7738-40DB-90E0-99DF62ECB767
P2860
Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.
@en
type
label
Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.
@en
prefLabel
Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.
@en
P2860
P356
P1476
Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.
@en
P2093
Andrew H Miller
Jennifer C Felger
P2860
P2888
P304
P356
10.1038/NPP.2016.167
P407
P577
2016-08-24T00:00:00Z
P6179
1036092203